Chronic Kidney Disease Trial, Recruiting (NCT07694791)

Chronic Kidney Disease Trial, Recruiting NCT07694791 Sponsor: Hospital Universitario Dr. Jose E. Gonzalez Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07694791 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older.
People who have been diagnosed with kidney disease and have been doing peritoneal dialysis at home for at least 1 month.

Who may not be able to join:

People who are unable to eat or receive nutrition through a feeding tube.
People who have taken prebiotic or probiotic supplements (products that support gut health) in the month before the trial begins.
People who have used antibiotics in the month before the trial begins.
People who are not able to attend the scheduled follow-up appointments — missing the second follow-up visit may result in removal from the study.
People who are unlikely to take their assigned capsules consistently — taking less than 80% of the total capsules provided may result in removal from the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elisa María Guadalupe Guerrero González, MD, Hospital Universitario. Dr. José Eleuterio González

Phone: 528182803788

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07694791

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 528182803788

More information: https://clinicaltrials.gov/study/NCT07694791

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older.
People who have been diagnosed with kidney disease and have been doing peritoneal dialysis at home for at least 1 month.

Who may not be able to join:

People who are unable to eat or receive nutrition through a feeding tube.
People who have taken prebiotic or probiotic supplements (products that support gut health) in the month before the trial begins.
People who have used antibiotics in the month before the trial begins.
People who are not able to attend the scheduled follow-up appointments — missing the second follow-up visit may result in removal from the study.
People who are unlikely to take their assigned capsules consistently — taking less than 80% of the total capsules provided may result in removal from the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez

Registry

ClinicalTrials.gov

Start date

3 October 2025

Est. completion

1 June 2027

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Change from baseline in serum high-sensitivity C-reactive protein (hs-CRP) at 3 and 6 months.; Change from baseline in Erythrocyte Sedimentation Rate (ESR) at 3 and 6 months.; Change from baseline in serum p-Cresyl Sulfate (pCS) levels at 3 and 6 months.; Change from baseline in serum Indoxyl Sulfate (IS) levels at 3 and 6 months.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov